ТОП просматриваемых книг сайта:
Долгая жизнь с муковисцидозом. Коллектив авторов
Читать онлайн.Название Долгая жизнь с муковисцидозом
Год выпуска 2015
isbn 978-5-4461-0329-4
Автор произведения Коллектив авторов
Жанр Здоровье
Издательство Автор
89
Plant BJ,GossCH, Plant WD, et al. Management of comorbidities in older patients with cystic fibrosis. Lancet Resp Med 2013; 1: 164-74.
90
Hodson ME, Simmonds NJ, Warwick WJ, et al. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros 2008; 7: 537-42.
91
Simmonds NJ, Cullinan R Hodson ME. Growing old with cystic fibrosis – the characteristics of long-term survivors of cystic fibrosis. Respir Med 2009; 103: 629-35.
92
Moran A, Becker D, Casella SJ, et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010;33:2677-83.
93
Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2013; 7: CD004730.
94
Morales MM, Falkenstein D, Lopes AG. The cystic fibrosis transmembrane regulator (CFTR) in the kidney. An Acad Bras Cienc 2000; 72: 399–406.
95
Jouret F, Devuyst O. CFTRand defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Arch 2009; 457: 1227-36.
96
Chamnan P, Shine BS, Haworth CS, et al. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010; 33: 311-16.
97
Koch C, Rainisio M, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus istightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001: 32: 343-50.
98
Rosenecker J, Hofler R, Steinkamp G, et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001: 6: 345-50.
99
Marshall ВС, Butler SM, Stoddard M, et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005:146: 681-7.
100
Schwarzenberg SJ, Thomas W, Olsen TW, et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007:30: 1056-61.
101
Wilschanski M, Durie PR. Patterns of Gl disease in adulthood associated with mutations in the CFTR gene. Gut 2007; 56:1153-63.
102
Rowland M, Gallagher CG, O'Laoide R, et al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011;106:104-9.
103
Chryssostalis A, Hubert D, Coste J, et al. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. J Hepatol 2011; 55: 1377-82.
104
Nash EF, Volling C, Gutierrez CA, et al. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 2012; 26: 34–41.
105
AndrieuxA, HarambatJ, BuiS, et al. Renal impairment in children with cystic fibrosis. J Cyst Fibros 2010;9:263-8.
106
O'Connell OJ, Harrison MJ, Murphy DM, et al. Peri-lung transplant renal issues in patients with cystic fibrosis. Chest 2013; 143: 271.
107
Quon BS, Mayer-Hamblett N, Aitken ML, et al. Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Ca re Med 2011; 184:1147-52.
108
Paccou J, Zeboulon N, Combescure C, et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010; 86: 1–7.
109
Quon BS, Aitken ML. Cystic fibrosis: what to expect now in the early adult years. Paediatr Respir Rev 2012; 13:206-14.
110
Bray F, Moller B. Predicting the future burden of cancer. Nat Rev Cancer 2006; 6: 63–74.
111
Maisonneuve R Marshall ВС, Knapp EA, et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 2013; 105: 122-9.
112
Smith DJ, Anderson GJ, Lamont IL, et al. Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation. J Cyst Fibros 2013; 12: 303-4.
113
Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332: 494-9.
114
Maisonneuve P, FitzSimmons SC, Neglia JP, et al. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 2003; 95: 381-7
115
Johannesson M, Askling J, Montgomery SM, et al. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer 2009; 125: 2953-6.
116
Ploessl C, Pettit RS, Donaldson J. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother 2014; 48: 488-93.
117
Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132: 231-7.
118
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
119
Ploessl C, Pettit RS, Donaldson J. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother 2014; 48: 488-93.
120
Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132: 231-7.
121
LiouTG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 1053-9.
122
Mayer-Hamblett